<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03222635</url>
  </required_header>
  <id_info>
    <org_study_id>NL6116501817</org_study_id>
    <nct_id>NCT03222635</nct_id>
  </id_info>
  <brief_title>Prospective Endoscopic Follow-up of Patients With Submucosal Esophageal Adenocarcinoma (The PREFER Trial)</brief_title>
  <official_title>Endoscopic Management of Patients With T1bN0M0 Esophageal Adenocarcinoma: a Prospective Multicenter Registry.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of this prospective multicenter study is to evaluate the safety of an endoscopic
      follow-up strategy in patients treated with endoscopic resection (ER) for submucosal
      esophageal adenocarcinoma (T1bN0M0 EAC).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Traditionally, the risk of lymph node metastasis associated with submucosal EAC was
      considered too high to offer these patients endoscopic follow-up. Only in elderly patients
      with comorbidity, more often an endoscopic protocol is selected. However, the risk of lymph
      node metastasis associated with submucosal EAC is mainly based on surgical series. Recently a
      number of studies, which included patients treated endoscopically, were published indicating
      that the risk of lymph node metastasis may be much lower than generally assumed.Therefore, a
      less invasive and organ preserving approach may not only be an option in the frail and
      elderly, but for all patients with submucosal EAC's.

      Aim of this multicenter study is to prospectively evaluate the safety of endoscopic follow-up
      in patients treated by endoscopic resection for submucosal (T1bN0M0) EAC.

      High-resolution upper endoscopy with white-light endoscopy and narrow-band imaging
      supplemented with an EUS are performed every three months during the first two years after
      ER. During the third and fourth year of follow-up, EUS and upper endoscopy are performed
      every six months. From the fifth year on, EUS and upper endoscopy are performed annually.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 25, 2017</start_date>
  <completion_date type="Anticipated">July 25, 2024</completion_date>
  <primary_completion_date type="Anticipated">July 25, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>5-year disease-specific mortality/survival</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lymph node metastasis, confirmed by cytology and/or histology</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Local recurrence eligible for endoscopic therapy</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Local recurrence requiring surgical therapy</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distant metastasis, histologically proven</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">141</enrollment>
  <condition>Submucosal Esophageal Adenocarcinoma</condition>
  <condition>Barrett Esophagus</condition>
  <arm_group>
    <arm_group_label>Endoscopic follow-up</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients treated with endoscopic resection (ER) for a submucosal esophageal adenocarcinoma without lymphnode- or distant metastases (T1bN0M0 EAC) will undergo endoscopic follow-up.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic follow-up</intervention_name>
    <description>Endoscopic follow-up by means of regular upper endoscopies and endoscopic ultrasounds</description>
    <arm_group_label>Endoscopic follow-up</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with submucosal EAC diagnosed in an ER specimen, revised by a panel of expert
             gastrointestinal (GI) pathologists.

          -  Signed informed consent.

        Exclusion Criteria:

          -  Prior history of esophageal cancer â‰¥T1sm.

          -  Synchronous esophageal squamous cell carcinoma.

          -  Suspicion on lymph node metastasis or distant metastasis on EUS, ultrasound of the
             neck or CT-thorax-abdomen performed six weeks after ER during baseline measurement.

          -  Tumor-positive deep resection margin (R1) in ER specimen.

          -  Patients unable to give signed informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J. J. Bergman, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>R. E. Pouw, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>K. Belghazi, MD</last_name>
    <phone>+31205662806</phone>
    <email>k.belghazi@amc.uva.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>W. D. Rosmolen</last_name>
    <phone>+31205663252</phone>
    <email>w.d.rosmolen@amc.uva.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UZ Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>R. Bisschops, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>R. Bisschops, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>K. Belghazi, MD, PhD</last_name>
      <phone>+31205662806</phone>
      <email>k.belghazi@amc.uva.nl</email>
    </contact>
    <contact_backup>
      <last_name>W. D. Rosmolen</last_name>
      <phone>+31205663252</phone>
      <email>w.d.rosmolen@amc.uva.nl</email>
    </contact_backup>
    <investigator>
      <last_name>J. J. Bergman, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>R. E. Pouw, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Catharina Hospital</name>
      <address>
        <city>Eindhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>E. J. Schoon, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>E. J. Schoon, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>W. B. Nagengast, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>W. B. Nagengast, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>B. L. Weusten, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>B. L. Weusten, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erasmus MC - University Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>A. D. Koch, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>A. D. Koch, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Haga Medical Center</name>
      <address>
        <city>The Hague</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>M. Houben, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>M. Houben, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Isala Clinics</name>
      <address>
        <city>Zwolle</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>B. E. Schenk, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>B. E. Schenk, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University College London Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>R. Haidry, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>R. Haidry, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Netherlands</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2017</study_first_submitted>
  <study_first_submitted_qc>July 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2017</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>prof. dr. J.J.G.H.M. Bergman</investigator_full_name>
    <investigator_title>Professor of Gastrointestinal Endoscopy</investigator_title>
  </responsible_party>
  <keyword>Barrett's esophagus</keyword>
  <keyword>Submucosal esophageal adenocarcinoma</keyword>
  <keyword>Endoscopic treatment</keyword>
  <keyword>Endoscopic follow-up</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Barrett Esophagus</mesh_term>
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

